By interacting with specific receptors in the body, they slow down gastric motility which creates a sense of fullness, causing individuals to consume fewer calories, which can lead to faster weight loss
Liu T, Cui L, Xue H, et al
Why GLP-1 Medications Cause GI Issues GLP-1 medications like semaglutide (Ozempic, Wegovy), liraglutide (Saxenda, Victoza), and tirzepatide (Mounjaro, Zepbound) are effective for managing type 2 diabetes and aiding weight loss, but up to 40% of patients experience gastrointestinal (GI) side effects
Its common for the face to develop sagging and hollow areas after weight loss
If you suspect an adverse reaction to your GLP-1 medicine, you can report it through the MHRA Yellow Card scheme at yellowcard